{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:16:25Z","timestamp":1776791785229,"version":"3.51.2"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.mcna.2017.10.002","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T19:00:12Z","timestamp":1517598012000},"page":"231-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Kidney, Ureteral, and Bladder Cancer"],"prefix":"10.1016","volume":"102","author":[{"given":"Hans C.","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Fascelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JJ.H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Isharwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib1","first-page":"41","article-title":"Metastatic renal cell carcinoma risk according to tumor size","volume":"182","author":"Thompson","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.urology.2006.04.011","article-title":"Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging","volume":"68","author":"Kutikov","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.mcna.2017.10.002_bib3","series-title":"Campbell-walsh urology","first-page":"1314","article-title":"Malignant renal tumors","author":"Campbell","year":"2016"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur Urol"},{"issue":"15","key":"10.1016\/j.mcna.2017.10.002_bib6","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.2010.30.9484","article-title":"Cigarette smoking is associated with advanced renal cell carcinoma","volume":"29","author":"Tsivian","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/aje\/kwn122","article-title":"Body Size and renal cell cancer incidence in a large US cohort study","volume":"168","author":"Adams","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.mcna.2017.10.002_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ijc.2910610503","article-title":"International renal-cell cancer study. IV. Occupation","volume":"61","author":"Mandel","year":"1995","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib9","first-page":"1309","article-title":"Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma","volume":"183","author":"Leibovich","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.mcna.2017.10.002_bib10","first-page":"2217","article-title":"Solid renal tumors: an analysis of pathological features related to tumor size","volume":"170","author":"Frank","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.mcna.2017.10.002_bib11","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.mcna.2017.10.002_bib12","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics","volume":"22","author":"Linehan","year":"2012","journal-title":"Genome Res"},{"issue":"20","key":"10.1016\/j.mcna.2017.10.002_bib13","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.93.20.10589","article-title":"Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene","volume":"93","author":"Gnarra","year":"1996","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"5","key":"10.1016\/j.mcna.2017.10.002_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1681\/ASN.2008070730","article-title":"Combining GFR and albuminuria to classify CKD improves prediction of ESRD","volume":"20","author":"Hallan","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib15","first-page":"989","article-title":"Management of renal masses and localized renal cancer: systematic review and meta-analysis","volume":"196","author":"Pierorazio","year":"2016","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib16","first-page":"2077","article-title":"Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model","volume":"188","author":"Kutikov","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib17","first-page":"1889","article-title":"Decline in renal function after partial nephrectomy: etiology and prevention","volume":"193","author":"Mir","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib18","first-page":"6790","article-title":"Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula","volume":"20","author":"Kopp","year":"2013","journal-title":"Can J Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1148\/radiol.13112617","article-title":"Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT","volume":"267","author":"Young","year":"2013","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2011.03.029","article-title":"Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score","volume":"60","author":"Kutikov","year":"2011","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.mcna.2017.10.002_bib21","doi-asserted-by":"crossref","first-page":"E374","DOI":"10.1111\/bju.12149","article-title":"Impact of tumour morphology on renal function decline after partial nephrectomy","volume":"111","author":"Mehrazin","year":"2013","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib22","first-page":"520","article-title":"Renal mass and localized renal cancer: AUA guideline","volume":"198","author":"Campbell","year":"2017","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.mcna.2017.10.002_bib23","series-title":"Campbell-Walsh urology","first-page":"1300","article-title":"Benign renal tumors","author":"Margulis","year":"2016"},{"issue":"5","key":"10.1016\/j.mcna.2017.10.002_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrurol.2013.62","article-title":"Active surveillance of small renal masses","volume":"10","author":"Smaldone","year":"2013","journal-title":"Nat Rev Urol"},{"issue":"13","key":"10.1016\/j.mcna.2017.10.002_bib25","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/cncr.24338","article-title":"Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance","volume":"115","author":"Crispen","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib26","first-page":"1227","article-title":"Excise, ablate or observe: the small renal mass dilemma\u2014A meta-analysis and review","volume":"179","author":"Kunkle","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eururo.2011.03.030","article-title":"Active surveillance of small renal masses: progression patterns of early stage kidney cancer","volume":"60","author":"Jewett","year":"2011","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.mcna.2017.10.002_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.eururo.2011.02.023","article-title":"Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance","volume":"59","author":"Mason","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib29","first-page":"1271","article-title":"Guideline for management of the clinical T1 renal mass","volume":"182","author":"Campbell","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.mcna.2017.10.002_bib30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00464-014-3807-0","article-title":"Endoscopic robot-assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative results","volume":"29","author":"Minervini","year":"2015","journal-title":"Surg Endosc"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib31","first-page":"1066","article-title":"Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7\u00a0cm results in outcome similar to radical nephrectomy","volume":"171","author":"Leibovich","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2010.10.002","article-title":"\u201cZero ischemia\u201d partial nephrectomy: novel laparoscopic and robotic technique","volume":"59","author":"Gill","year":"2011","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.mcna.2017.10.002_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib34","first-page":"51","article-title":"Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis","volume":"188","author":"Kim","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib35","first-page":"55","article-title":"Partial nephrectomy versus radical nephrectomy in patients with small renal tumors\u2014Is there a difference in mortality and cardiovascular outcomes?","volume":"181","author":"Huang","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A\u00a0prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Van Poppel","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib37","first-page":"41","article-title":"Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors","volume":"178","author":"Gill","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib38","first-page":"1291","article-title":"Percutaneous renal cryoablation: local control at mean 26\u00a0months of followup","volume":"184","author":"Atwell","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"36","key":"10.1016\/j.mcna.2017.10.002_bib39","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1200\/JCO.2014.56.5416","article-title":"Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines","volume":"32","author":"Stewart","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0094-0143(03)00056-9","article-title":"Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease","volume":"30","author":"Janzen","year":"2003","journal-title":"Urol Clin North Am"},{"issue":"23","key":"10.1016\/j.mcna.2017.10.002_bib41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa003013","article-title":"Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer","volume":"345","author":"Flanigan","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"9286","key":"10.1016\/j.mcna.2017.10.002_bib42","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","article-title":"Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial","volume":"358","author":"Mickisch","year":"2001","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.mcna.2017.10.002_bib43","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2217\/fon-2017-0083","article-title":"The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape","volume":"13","author":"Goebell","year":"2017","journal-title":"Future Oncol"},{"issue":"5","key":"10.1016\/j.mcna.2017.10.002_bib44","article-title":"Immunotherapy for metastatic renal cell carcinoma","author":"Unverzagt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib45","first-page":"1934","article-title":"A\u00a0combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer","volume":"156","author":"Pawinski","year":"1996","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00345-011-0709-9","article-title":"Impact of gender on bladder cancer incidence, staging, and prognosis","volume":"29","author":"Fajkovic","year":"2011","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib48","first-page":"25","article-title":"Management of high grade transitional cell cancer of the upper urinary tract","volume":"125","author":"Murphy","year":"1981","journal-title":"J\u00a0Urol"},{"issue":"7","key":"10.1016\/j.mcna.2017.10.002_bib49","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/1097-0142(19920401)69:7<1773::AID-CNCR2820690720>3.0.CO;2-0","article-title":"Renal pelvic transitional cell carcinoma. The role of the kidney in tumor-node-metastasis staging","volume":"69","author":"Guinan","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00365599209181226","article-title":"Carcinoma of the renal pelvis. Experience of 80 cases","volume":"26","author":"Raabe","year":"1992","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib51","first-page":"350","article-title":"The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis","volume":"141","author":"Mariani","year":"1989","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib52","first-page":"524","article-title":"A\u00a0prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice","volume":"163","author":"Khadra","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","article-title":"Guidelines on bladder cancer","volume":"41","author":"Oosterlinck","year":"2002","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.mcna.2017.10.002_bib54","first-page":"503","article-title":"Epidemiology of renal and ureteral cancer in Rochester, Minnesota, 1950-1974, with special reference to clinical and pathologic features","volume":"53","author":"Resseguie","year":"1978","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ijc.2910410414","article-title":"The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures","volume":"41","author":"Jensen","year":"1988","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.mcna.2017.10.002_bib56","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","article-title":"Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract","volume":"104","author":"Colin","year":"2009","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.mcna.2017.10.002_bib58","series-title":"Campbell-Walsh urology","first-page":"1516","article-title":"Urothelial tumors of the upper urinary tract and ureter","author":"Sagalowsky","year":"2012"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib59","first-page":"24","article-title":"The Lynch syndrome II and urological malignancies","volume":"143","author":"Lynch","year":"1990","journal-title":"J\u00a0Urol"},{"issue":"18","key":"10.1016\/j.mcna.2017.10.002_bib60","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","article-title":"Molecular evidence supporting field effect in urothelial carcinogenesis","volume":"11","author":"Jones","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mcna.2017.10.002_bib61","first-page":"1035","article-title":"Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis","volume":"181","author":"Wright","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib62","first-page":"2046","article-title":"Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients","volume":"188","author":"Picozzi","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.mcna.2017.10.002_bib63","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2014.81","article-title":"Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression","volume":"28","author":"Lochhead","year":"2015","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib65","first-page":"2473","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis","year":"2012","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib66","first-page":"600","article-title":"Urine based markers of urological malignancy","volume":"165","author":"Konety","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cancergencyto.2008.10.015","article-title":"Utility of fluorescence in\u00a0situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma","volume":"189","author":"Luo","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib68","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.eururo.2006.08.045","article-title":"Utility of fluorescence in\u00a0situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma","volume":"51","author":"Mar\u00edn-Aguilera","year":"2007","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.mcna.2017.10.002_bib69","doi-asserted-by":"crossref","first-page":"531.e15-22","DOI":"10.1016\/j.urolonc.2017.03.008","article-title":"Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma","volume":"35","author":"Lotan","year":"2017","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib70","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib71","first-page":"2414","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib72","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2253011515","article-title":"Multi-detector row CT urography: comparison of strategies for depicting the normal urinary collecting system","volume":"225","author":"McTavish","year":"2002","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rcl.2016.10.008","article-title":"Upper and lower tract urothelial imaging using computed tomography urography","volume":"55","author":"Raman","year":"2017","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib74","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.crad.2006.10.008","article-title":"Multidetector computed tomography urography (MDCTU) for diagnosing urothelial malignancy","volume":"62","author":"Anderson","year":"2007","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/iju.13032","article-title":"Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma","volume":"23","author":"Jinzaki","year":"2016","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.urolonc.2004.10.010","article-title":"Endoscopic treatment of upper tract transitional cell carcinoma","volume":"23","author":"Soderdahl","year":"2005","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib77","first-page":"33","article-title":"Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma","volume":"157","author":"Keeley","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib78","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.urology.2003.10.076","article-title":"Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma","volume":"63","author":"El-Hakim","year":"2004","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib79","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2011.02.038","article-title":"Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0094-0143(21)01097-1","article-title":"Upper urinary tract urothelial tumors","volume":"3","author":"Batata","year":"1976","journal-title":"Urol Clin North Am"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib81","first-page":"1536","article-title":"Bladder leiomyoma","volume":"189","author":"Goel","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/106689690501300203","article-title":"The 2004 WHO classification of bladder tumors: a summary and commentary","volume":"13","author":"Montironi","year":"2005","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib83","first-page":"2535","article-title":"Nephrogenic adenoma of the bladder","volume":"184","author":"Pavlidakey","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.mcna.2017.10.002_bib84","series-title":"AJCC cancer staging manual","first-page":"749","article-title":"Renal pelvis and ureter","author":"McKiernan","year":"2017"},{"issue":"3 SUPPL. 1","key":"10.1016\/j.mcna.2017.10.002_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2006.01.037","article-title":"The pathology of bladder cancer","volume":"67","author":"Reuter","year":"2006","journal-title":"Urology"},{"issue":"10061","key":"10.1016\/j.mcna.2017.10.002_bib86","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mcna.2017.10.002_bib87","first-page":"86","article-title":"Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in\u00a0situ of the bladder: a meta-analysis of the published results of randomized clinical trials","volume":"174","author":"Sylvester","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mcna.2017.10.002_bib88","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer","volume":"56","author":"Malmstrom","year":"2009","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib89","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1464-410x.2001.02306.x","article-title":"A\u00a0systematic review of intravesical bacillus Calmette-Gu\u00e9rin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer","volume":"88","author":"Shelley","year":"2001","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib90","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.urology.2008.12.047","article-title":"Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors","volume":"73","author":"Palou","year":"2009","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib91","first-page":"1214","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.mcna.2017.10.002_bib92","series-title":"Campbell\u2019s urology","first-page":"2327","article-title":"Urothelial tumors of the urinary tract","author":"Messing","year":"1998"},{"issue":"3","key":"10.1016\/j.mcna.2017.10.002_bib93","first-page":"900","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.mcna.2017.10.002_bib94","first-page":"1271","article-title":"Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter","volume":"172","author":"Czito","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.mcna.2017.10.002_bib95","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0360-3016(92)90723-U","article-title":"Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter","volume":"24","author":"Cozad","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.mcna.2017.10.002_bib96","unstructured":"Edge, S, Byrd, DR, Compton, CC, et\u00a0al. AJCC cancer staging manual | Stephen Edge | Springer. Springer."},{"issue":"6","key":"10.1016\/j.mcna.2017.10.002_bib97","first-page":"1069","article-title":"Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer","volume":"131","author":"Skinner","year":"1984","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.mcna.2017.10.002_bib98","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2017.01.007","article-title":"A\u00a0review on the evolution of PD-1\/PD-L1 immunotherapy for bladder cancer: the future is now","volume":"54","author":"Bellmunt","year":"2017","journal-title":"Cancer Treat Rev"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712517301566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712517301566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T21:09:23Z","timestamp":1660424963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712517301566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0025712517301566"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2017.10.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney, Ureteral, and Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}